Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Solomon

Showing results (261-270 of 1,423) with videos related to

Pageof 143
Sort By:
European Journal of Heart Failure|April 1, 2016
Influence of cigarette smoking on cardiac biomarkers: the Atherosclerosis Risk in Communities (ARIC) StudyWilson Nadruz, Alexandra Gonçalves, Brian Claggett, et al.
JAMA|June 25, 2025
Randomized Experiment of Recruitment Letter Design to Maximize Clinical Trial EnrollmentNiklas Dyrby Johansen, David Preiss, Marion Mafham, et al.
The American Journal of Cardiology|April 22, 2011
Opposing effects of β blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery diseaseOrly Vardeny, Hajime Uno, Eugene Braunwald, et al.
International Journal of Cardiology|February 6, 2025
Myocardial contraction fraction predicts outcomes in patients enrolled in the TOPCAT trialBryton J Davis, Morris Kim, Yunwoo Burton, et al.
Journal of Hypertension|December 7, 2013
Age and the effectiveness of anti-hypertensive therapy on improvement in diastolic functionSusan Cheng, Carolyn Lam, Amil Shah, et al.
European Heart Journal|January 12, 2010
Cardiovascular manifestations of Fabry disease: relationships between left ventricular hypertrophy, disease severity, and alpha-galactosidase A activityJustina C Wu, Carolyn Y Ho, Hicham Skali, et al.
Circulation|January 21, 2009
Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophyScott D Solomon, Evan Appelbaum, Warren J Manning, et al.
JACC. Heart Failure|November 3, 2022
Steroidal MRA Across the Spectrum of Renal Function: A Pooled Analysis of RCTsJoão Pedro Ferreira, Bertram Pitt, John J V McMurray, et al.
The American Journal of Cardiology|December 3, 2014
Outcomes of patients with anemia and acute decompensated heart failure with preserved versus reduced ejection fraction (from the ARIC study community surveillance)Melissa C Caughey, Christy L Avery, Hanyu Ni, et al.
European Journal of Heart Failure|March 3, 2020
Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failurePooja Dewan, Alice Jackson, Carolyn S P Lam, et al.
Pageof 143

Showing results (261-270 of 1,423) with videos related to

Sort By:
Pageof 143
European Journal of Heart Failure|April 1, 2016
Influence of cigarette smoking on cardiac biomarkers: the Atherosclerosis Risk in Communities (ARIC) StudyWilson Nadruz, Alexandra Gonçalves, Brian Claggett, et al.
JAMA|June 25, 2025
Randomized Experiment of Recruitment Letter Design to Maximize Clinical Trial EnrollmentNiklas Dyrby Johansen, David Preiss, Marion Mafham, et al.
The American Journal of Cardiology|April 22, 2011
Opposing effects of β blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery diseaseOrly Vardeny, Hajime Uno, Eugene Braunwald, et al.
International Journal of Cardiology|February 6, 2025
Myocardial contraction fraction predicts outcomes in patients enrolled in the TOPCAT trialBryton J Davis, Morris Kim, Yunwoo Burton, et al.
Journal of Hypertension|December 7, 2013
Age and the effectiveness of anti-hypertensive therapy on improvement in diastolic functionSusan Cheng, Carolyn Lam, Amil Shah, et al.
European Heart Journal|January 12, 2010
Cardiovascular manifestations of Fabry disease: relationships between left ventricular hypertrophy, disease severity, and alpha-galactosidase A activityJustina C Wu, Carolyn Y Ho, Hicham Skali, et al.
Circulation|January 21, 2009
Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophyScott D Solomon, Evan Appelbaum, Warren J Manning, et al.
JACC. Heart Failure|November 3, 2022
Steroidal MRA Across the Spectrum of Renal Function: A Pooled Analysis of RCTsJoão Pedro Ferreira, Bertram Pitt, John J V McMurray, et al.
The American Journal of Cardiology|December 3, 2014
Outcomes of patients with anemia and acute decompensated heart failure with preserved versus reduced ejection fraction (from the ARIC study community surveillance)Melissa C Caughey, Christy L Avery, Hanyu Ni, et al.
European Journal of Heart Failure|March 3, 2020
Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failurePooja Dewan, Alice Jackson, Carolyn S P Lam, et al.
Pageof 143